Sonnet Biotherapeutics Holdings Inc
Change company Symbol lookup
Select an option...
SONN Sonnet Biotherapeutics Holdings Inc
GME GameStop Corp
IKNX Ikonics Corp
EGAN eGain Corp
SMED Sharps Compliance Corp
CUB Cubic Corp
CHGG Chegg Inc
RIO Rio Tinto PLC
PTOS P2 Solar Inc
LUV Southwest Airlines Co
Go

Company profile

Sonnet Biotherapeutics Holdings Inc, formerly Chanticleer Holdings, Inc., an oncology-focused biotechnology company. The Company is developing targeted biologic drugs with enhanced single or bispecific mechanisms.

Price
Delayed
$2.12
Day's Change
-0.0001 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.12
Day's Low
2.07
Volume
(Light)

Today's volume of 103,052 shares is on pace to be much lighter than SONN's 10-day average volume of 537,312 shares.

103,052

There are no calendar events for SONN

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.